Gut Microbiome Basic Test

Includes all microorganisms that colonise the gut

A balanced ratio of intestinal bacteria is of crucial importance for human health. As many studies have shown, an imbalance in the gut microbiome is associated with various diseases. These include metabolic syndrome, diabetes, inflammatory bowel diseases such as Crohn's disease and ulcerative colitis, irritable bowel syndrome, calcium oxalate urinary stones, cardiovascular diseases, rheumatoid arthritis and neurological disorders.

The method known as next-generation sequencing for identifying dysbiosis has so far only been used in scientific studies. It involves the molecular genetic analysis of the entire bacterial intestinal microbiome and represents a revolution in diagnostics, as conventional stool diagnostics could only identify a limited proportion of the intestinal bacteria present. In addition, a more precise assessment of the effects of the individual, highly complex microbiota on colonisation resistance, digestive processes, nutrient and vitamin absorption and immunity is possible.

Even anaerobic bacteria, which cannot be cultured, can be analysed. In the 20th century, microbiological stool diagnostics were largely based on cultural cultivation on culture media and subsequent enzymatic differentiation. However, very few of the anaerobic bacteria (around 99% of intestinal bacteria) grow using cultural methods. The methods of analysis have developed rapidly in recent years. In modern laboratories, the identification of bacteria from the sample is now largely carried out by mass spectrometry (MALDI-TOF = Matrix Assisted Laser Desorption Ionisation-Time of Flight) on culture media or by molecular biological methods (PCR = Polymerase Chain Reaction) directly from the material sent in. One disadvantage, however, is that PCR technology is very selective and cost-intensive.

The microbiome data and its expertise can be regularly updated and expanded in the future to take new findings into account.

A microbiome stool test can be carried out from the age of 3.

The examination at the molecular genetic level includes

• Analysis of the diversity of the intestinal microbiome
• Assessment of bacterial dysbiosis
• Determination of the enterotype
• Distribution frequency of the most important bacterial strains
• Determination of the ratio of Firmicutes to Bacteroidetes
• Evaluation of the mucosaprotective flora
• Investigation of risk factors for diseases associated with dysbiosis

• 1 sample collection guide
• 1 instruction sheet
• 1 sample accompanying document
• 1 guarantee document
• 1 sample container with label in the shipping container
• 1 microbiome sample tube with label in the shipping container
• 1 stool collection device
• 1 shipping container
• 1 shipping envelope

How does the ordering process work?

Once you have placed your order, you will be sent the desired test pack with detailed instructions. You put your sample in a sample container, send it in a prepared envelope to Medivere's partner laboratory GANZIMMUN Diagnostics GmbH and receive a report with the evaluation of your profile after 5-7 days.

Only for Germany and Austria

We would like to point out that these tests and the shipping procedures are optimised and pre-paid for Germany and Austria. Orders from further afield are problematic because the perishable biological samples may only be in transit for a limited time (maximum 4 days). Customers from Switzerland or other EU countries can of course try it at their own risk, but if the test fails, we decline any responsibility or reimbursement. You can find more information on this from the manufacturer!